Search Results 1241-1250 of 19374 for Hemoglobin

1. Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

   You have a neutrophil count (type of white blood cell) less than 1500/mm3, platelet count less than 50,000/mm3, or a hemoglobin less than 7 g/dL; You have an ...

2. Study Of GI-102 And PD-1 In Glioblastoma - Mayo Clinic

   Participation eligibility · Hemoglobin ≥9.0 g/dL · Absolute neutrophil count (ANC) ≥1500/mm3 · Platelet count ≥100,000/mm3 · Creatinine ≤1.5 x ULN OR measured ...

3. An Expanded Access Study of Iniparib Combined with Gemcitabine and Carboplatin for the Treatment of Breast Cancer - Mayo Clinic

   Participation eligibility · Absolute neutrophil count (ANC) ≥1500/mm3 · Platelets ≥100,000/dL · Hemoglobin ≥9 g/dL · Bilirubin ≤1.5 mg/dL · Serum creatinine ≤ ...

4. S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer - Mayo Clinic

   Hemoglobin ≥ 9 g/dL. Platelet count ≥ 100,000/mL. Bilirubin ≤ 1.5 mg/dL ... Patients previously diagnosed with diabetes must not have uncontrolled diabetes ( ...

5. Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL;; Total bilirubin ≤ 1.5 X upper limit of normal (ULN); if total bilirubin > 1.5 X ULN then direct bilirubin ≤ ULN;; Aspartate ...

6. A Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS) - Mayo Clinic

   A hemoglobin (Hb) concentration \<11.0 grams per deciliter (g/dL) during the 4-week Screening Period; 5. Eastern Cooperative Oncology Group (ECOG) ...

7. Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET - Mayo Clinic

   * Hemoglobin (Hb) ≥ 8 g/dL * Creatinine clearance \> 40 mL/min calculated by the Cockcroft Gault method * Total bilirubin ≤ 3 x ULN * Potassium within ...

8. Trial Of Neoadjuvant Enoblituzumab Vs SOC In Men With High-Risk Localized Prostate Cancer - Mayo Clinic

   - Hemoglobin >9.0 g/dL - Platelet count >100,000 cells/mm3 - Serum creatinine <1.5 × upper limit of normal (ULN) - Serum bilirubin <1.5 × ULN - ALT <3 × ULN

9. A Study to Evaluate the Safety and Effectiveness of Metformin and Nelfinavir with Bortezomib in Patients with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dL (No red cell transfusion should have been administered within 4 days of registration);; Absolute neutrophil count (ANC) ≥ 1000/mm^3 ...

10. Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy - Mayo Clinic

    -Hemoglobin >= 7.0 g/dL if asymptomatic or hemoglobin > 8 if symptomatic; transfusion support allowed, if necessary (obtained =< 14 days prior to registration).